EDGAR Filing Documents for 0001654954-17-005524

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001654954-17-005524

Filing Date

2017-06-13

Accepted

2017-06-13 16:05:48

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13D	azrx13d_june132017.htm	SC 13D	111140
	Complete submission text file	0001654954-17-005524.txt		112496

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D | Act: 34 | File No.: 005-89966 | Film No.: 17908891
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JDJ FAMILY OFFICE SERVICES P.O. BOX 962049 BOSTON MA 02196

Business Address

Ross Edmund Burke Jr. (Filed by) CIK: 0001682557 (see all company filings)

Type: SC 13D